Plasma homocysteine levels and the left ventricular systolic function in coronary artery disease patients
Authors:
- Syed W. BokhariSBSyed W. Bokhari
- Zubaria W. BokhariZBZubaria W. Bokhari
- Jason A. ZellJZJason A. Zell
- Don W. LeeDLDon W. Lee
- David P. FaxonDFDavid P. Faxon
- 1 May 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 16 (3) , 153-161
Abstract
Numerous studies have shown a relationship between hyperhomocysteinemia, atherothrombosis and cardiovascular mortality. However, an association between hyperhomocysteinemia and the extent of coronary artery disease (CAD) remains controversial whereas its relationship with left ventricular systolic function has not been established. One hundred and fifty-seven patients with angiographically defined CAD were included. The relationships between hyperhomocysteinemia, severity of CAD and left ventricular systolic function were studied. Left ventricular systolic function was determined primarily by ventriculography. The severity of CAD was determined through coronary angiography using the Gensini score and the number of vessels with ≥50% stenosis. The mean fasting plasma homocysteine level was 13.4 μmol/l±0.5 SE. Elevated levels of homocysteine correlated significantly with increased severity of CAD both by the Gensini scores (r-value=0.344, P<0.0005) and the total number of diseased vessels (r-value=0.387, P<0.0005). The patients with hyperhomocysteinemia were found to have significantly reduced left ventricular ejection fraction (r-value=−0.382, P<0.0005). A multivariate regression analysis revealed homocysteine level to be an independent predictor of left ventricular systolic function. In addition, adjusted analysis revealed hyperhomocysteinemia to be associated with global left ventricular dysfunction. In patients with CAD, homocysteine levels correlate independently with left ventricular systolic function. The mechanism of this association between homocysteine and left ventricular systolic function is unknown but may be due to a direct effect of homocysteine on myocardial function separate from its effects on coronary atherosclerosis.Keywords
This publication has 76 references indexed in Scilit:
- Association between total homocyst(e)ine and the likelihood for a history of acute myocardial infarction by race and ethnicity: Results from the Third National Health and Nutrition Examination surveyAmerican Heart Journal, 2000
- Correlation of homocysteine levels with the extent of coronary atherosclerosis in patients with low cardiovascular risk profilesThe American Journal of Cardiology, 2000
- Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuriaKidney International, 1999
- Total Homocyst(e)ine Concentration and the Likelihood of Nonfatal StrokeStroke, 1998
- HOMOCYSTEINE AND VASCULAR DYSFUNCTIONLife Sciences, 1997
- A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.Journal of the American College of Nutrition, 1996
- Homocysteine and coronary atherosclerosisJACC, 1996
- The case that hyperhomocysteinemia is a risk factor for coronary artery diseaseThe American Journal of Cardiology, 1994
- Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatmentAtherosclerosis, 1993
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991